Sichuan Huiyu Pharmaceutical Co., Ltd. (SHA:688553)

SHA:688553 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	1,082	1,085	926.02	1,490	1,820	1,358
Other Revenue	9.01	9.01	1.06	3.27	3.44	6.55
Revenue	1,091	1,094	927.08	1,493	1,824	1,364
Revenue Growth (YoY)	17.05%	18.05%	-37.92%	-18.12%	33.68%	92.94%
Cost of Revenue	186.01	187.58	132.75	180.12	160.19	120.91
Gross Profit	904.82	906.8	794.32	1,313	1,664	1,243
Selling, General & Admin	512.37	511.56	437.58	810.82	972.32	771.98
Research & Development	324.07	327.72	340.76	356.19	248.21	88.77
Other Operating Expenses	-0.41	6.57	6.72	7.83	9.57	5.34
Operating Expenses	834.6	845.82	787.93	1,176	1,230	865.56
Operating Income	70.22	60.98	6.39	136.66	433.49	377.72
Interest Expense	-10.32	-12.4	-6.7	-1.18	-1.06	-1.84
Interest & Investment Income	46.85	50.23	79.73	91.18	20.16	13.4
Currency Exchange Gain (Loss)	-0.78	-0.78	3.33	-0.13	-1.1	-1.45
Other Non Operating Income (Expenses)	-3.54	0.66	1.39	-5.16	-4.17	0.49
EBT Excluding Unusual Items	102.42	98.69	84.13	221.37	447.31	388.32
Gain (Loss) on Sale of Investments	158.01	239.86	6.44	2.33	6.16	-
Gain (Loss) on Sale of Assets	-0.32	-0.3	-	-0.03	-0.02	-0.82
Asset Writedown	-13.1	-9.6	-	-	-	-
Other Unusual Items	21.76	21.05	41.58	14.72	24.25	8.95
Pretax Income	268.76	349.7	132.15	238.39	477.7	396.46
Income Tax Expense	24.43	33.8	-7.18	-10.6	31.84	54.63
Earnings From Continuing Operations	244.33	315.9	139.33	248.99	445.86	341.82
Minority Interest in Earnings	9	9.49	0.45	-	-	1.5
Net Income	253.33	325.39	139.79	248.99	445.86	343.32
Net Income to Common	253.33	325.39	139.79	248.99	445.86	343.32
Net Income Growth	71.37%	132.78%	-43.86%	-44.16%	29.87%	94.03%
Shares Outstanding (Basic)	424	423	424	422	372	361
Shares Outstanding (Diluted)	424	423	424	422	372	361
Shares Change (YoY)	0.32%	-0.24%	0.37%	13.58%	2.81%	-
EPS (Basic)	0.60	0.77	0.33	0.59	1.20	0.95
EPS (Diluted)	0.60	0.77	0.33	0.59	1.20	0.95
EPS Growth	70.82%	133.33%	-44.07%	-50.83%	26.32%	-
Free Cash Flow	125.97	114.78	-229.79	-267.55	12.91	228.74
Free Cash Flow Per Share	0.30	0.27	-0.54	-0.63	0.04	0.63
Dividend Per Share	0.463	0.463	0.213	0.235	0.211	-
Dividend Growth	117.47%	117.47%	-9.36%	11.37%	-	-
Gross Margin	82.95%	82.86%	85.68%	87.94%	91.22%	91.14%
Operating Margin	6.44%	5.57%	0.69%	9.15%	23.77%	27.69%
Profit Margin	23.22%	29.73%	15.08%	16.67%	24.45%	25.17%
Free Cash Flow Margin	11.55%	10.49%	-24.79%	-17.92%	0.71%	16.77%
EBITDA	151.15	137.49	65.2	184.38	468.91	402.47
EBITDA Margin	13.86%	12.56%	7.03%	12.35%	25.71%	29.50%
D&A For EBITDA	80.94	76.51	58.81	47.72	35.43	24.75
EBIT	70.22	60.98	6.39	136.66	433.49	377.72
EBIT Margin	6.44%	5.57%	0.69%	9.15%	23.77%	27.69%
Effective Tax Rate	9.09%	9.67%	-	-	6.67%	13.78%
Revenue as Reported	1,091	1,094	927.08	1,493	1,824	1,364
Advertising Expenses	-	-	-	1	3.71	3.81

Source: S&P Global Market Intelligence. Standard template. Financial Sources.